|
|
News Breaks
|
November 18, 2009
|
| 09:48 EDT |  | CVM |
| theflyonthewall.com: | CEL-SCI Corp begins first clinical study of LEAPS-H1N1 | | CEL-SCI Corporation announced the start of the Company's first clinical study for hospitalized H1N1 patients at The Johns Hopkins University School of Medicine. The study is being led by Principal Investigator Jonathan M. Zenilman, MD, Professor of Medicine, Johns Hopkins School of Medicine and Chief of Infectious Diseases Division, Johns Hopkins Bayview Medical Center. This initial study will involve taking blood from 20 hospitalized, laboratory-confirmed H1N1 patients and activating their cells with the LEAPS-H1N1 investigational therapy in order to assess the cells' response as the basis for the planned future treatment of this patient population under a next-stage clinical trial protocol. In parallel, the study will involve taking blood from 20 healthy individuals not infected with H1N1 and activating their cells with the LEAPS-H1N1 investigational therapy to serve as a control for the patient group in the study. :theflyonthewall.com |
|
|
News For CVM From The Last 14 Days Check below for free stories on CVM the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
